{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T15:01:39Z","timestamp":1789916499227,"version":"4.0.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.seizure.2026.06.015","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T16:28:03Z","timestamp":1782318483000},"page":"26-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Expanding the genotypic landscape of the neuronal ceroid lipofuscinoses: clinical and molecular findings from a tertiary-care center in Argentina"],"prefix":"10.1016","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0207-9552","authenticated-orcid":false,"given":"Mar\u00eda Sol","family":"Touzon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Reyes Valenzuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Loos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1877-2287","authenticated-orcid":false,"given":"B\u00e1rbara","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Gauto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossana","family":"Obreg\u00f3n Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenaida E","family":"Chico Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Rugilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7085-3760","authenticated-orcid":false,"given":"Juan Pablo","family":"Princich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7251-7656","authenticated-orcid":false,"given":"Giovanna","family":"Aschettino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5527-3901","authenticated-orcid":false,"given":"Cristina","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matias","family":"Juanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto H","family":"Caraballo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.seizure.2026.06.015_bib0001","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.bbadis.2015.05.011","article-title":"Genetics of the neuronal ceroid lipofuscinoses (Batten disease)","volume":"1852","author":"Mole","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.seizure.2026.06.015_bib0002","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3390\/genes15020171","article-title":"Progressive myoclonus epilepsy: a scoping review of diagnostic, phenotypic and therapeutic advances","volume":"15","author":"Zimmern","year":"2024","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.seizure.2026.06.015_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.754045","article-title":"The genetic basis of phenotypic heterogeneity in the neuronal ceroid lipofuscinoses","volume":"12","author":"Gardner","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.seizure.2026.06.015_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.811686","article-title":"Neuronal ceroid lipofuscinosis: the multifaceted approach to the clinical issues, an overview","volume":"13","author":"Simonati","year":"2022","journal-title":"Front Neurol"},{"issue":"6","key":"10.1016\/j.seizure.2026.06.015_bib0005","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/epi.17240","article-title":"ILAE classification and definition of epilepsy syndromes with onset at a variable age","volume":"63","author":"Riney","year":"2022","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.seizure.2026.06.015_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2019.165570","article-title":"Pathomechanisms in the neuronal ceroid lipofuscinoses","volume":"1866","author":"Nelvagal","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"10","key":"10.1016\/j.seizure.2026.06.015_bib0007","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.3390\/ijms23105729","article-title":"Recent insight into the genetic basis, clinical features, and diagnostic methods for neuronal ceroid lipofuscinosis","volume":"23","author":"Kaminiow","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.seizure.2026.06.015_bib0008","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.12833","article-title":"Unifying biology of neurodegeneration in lysosomal storage diseases","volume":"48","author":"Ludlaim","year":"2025","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"10.1016\/j.seizure.2026.06.015_bib0009","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1212\/WNL.0b013e31825f0547","article-title":"New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses","volume":"79","author":"Williams","year":"2012","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.seizure.2026.06.015_bib0010","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/ana.25351","article-title":"KCTD7 deficiency defines a distinct neurodegenerative disorder with a conserved autophagy-lysosome defect","volume":"84","author":"Metz","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2026.06.015_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.920421","article-title":"Neuronal ceroid lipofuscinosis in the South American-caribbean region: an epidemiological overview","volume":"13","author":"Guelbert","year":"2022","journal-title":"Front Neurol"},{"issue":"5","key":"10.1016\/j.seizure.2026.06.015_bib0012","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.seizure.2026.06.015_bib0013","first-page":"149","article-title":"Ceroid-lipofuscinoses","volume":"8","author":"Aicardi","year":"1978","journal-title":"Rev EEG Neurophysiol"},{"key":"10.1016\/j.seizure.2026.06.015_bib0014","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.eplepsyres.2018.05.005","article-title":"Late-onset childhood neuronal ceroid lipofuscinosis: early clinical and electroencephalographic markers","volume":"144","author":"Beltr\u00e1n","year":"2018","journal-title":"Epilepsy Res"},{"issue":"1","key":"10.1016\/j.seizure.2026.06.015_bib0015","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ajhg.2012.05.023","article-title":"A homozygous mutation in KCTD7 links neuronal ceroid lipofuscinosis to the ubiquitin-proteasome system","volume":"91","author":"Staropoli","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"12","key":"10.1016\/j.seizure.2026.06.015_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2018.11.025","article-title":"Progressive myoclonus epilepsy and ceroidolipofuscinosis 14: the multifaceted phenotypic spectrum of KCTD7-related disorders","volume":"62","author":"Mastrangelo","year":"2019","journal-title":"Eur J Med Genet"},{"issue":"13","key":"10.1016\/j.seizure.2026.06.015_bib0017","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1177\/0883073816658659","article-title":"Unique characteristics of the photoparoxysmal response in patients with neuronal ceroid lipofuscinosis type 2: can EEG be a biomarker?","volume":"31","author":"Albert","year":"2016","journal-title":"J Child Neurol"},{"key":"10.1016\/j.seizure.2026.06.015_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.845877","article-title":"Neurophysiological findings in neuronal ceroid lipofuscinoses","volume":"13","author":"Trivisano","year":"2022","journal-title":"Front Neurol"},{"issue":"8","key":"10.1016\/j.seizure.2026.06.015_bib0019","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S2352-4642(18)30179-2","article-title":"Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study","volume":"2","author":"Nickel","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"issue":"1","key":"10.1016\/j.seizure.2026.06.015_bib0020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s40265-020-01440-7","article-title":"Neuronal ceroid lipofuscinosis: potential for targeted therapy","volume":"81","author":"Specchio","year":"2021","journal-title":"Drugs"},{"issue":"13","key":"10.1016\/j.seizure.2026.06.015_bib0021","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/hmg\/ddaf067","article-title":"Unraveling CLN7 disease: the distinct roles of two close MFSD8\/CLN7 splice variants in phenotypic expression","volume":"34","author":"Venier","year":"2025","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.seizure.2026.06.015_bib0022","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1474-4422(18)30368-5","article-title":"Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis","volume":"18","author":"Mole","year":"2019","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.seizure.2026.06.015_bib0023","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70261","article-title":"Neuronal ceroid lipofuscinosis: concepts, classification, and avenues for therapy","volume":"31","author":"Zhang","year":"2025","journal-title":"CNS Neurosci Ther"},{"issue":"20","key":"10.1016\/j.seizure.2026.06.015_bib0024","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1056\/NEJMoa1712649","article-title":"Study of intraventricular cerliponase alfa for CLN2 disease","volume":"378","author":"Schulz","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seizure.2026.06.015_bib0025","article-title":"Classic and atypical late infantile neuronal ceroid lipofuscinosis in Latin America: clinical and genetic aspects, and treatment outcome with cerliponase alfa","volume":"38","author":"Guelbert","year":"2024","journal-title":"Mol Genet Metab Rep"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131126001871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131126001871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:26:05Z","timestamp":1789914365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131126001871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":25,"alternative-id":["S1059131126001871"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2026.06.015","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expanding the genotypic landscape of the neuronal ceroid lipofuscinoses: clinical and molecular findings from a tertiary-care center in Argentina","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2026.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 British Epilepsy Association. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}